Episode 157: Pump Therapy
Typical treatment of Parkinson’s disease (PD) consists of oral levodopa/carbidopa, along with other oral medications. Although there is no one-size fits all treatment, people with PD may experience more “off” periods, or symptom fluctuations, as the disease progresses. In this case, non-oral treatments, such as pump therapy, may be another option to consider.
Examples of currently available pump therapies for Parkinson’s include medication, namely apomorphine, delivered under the skin (subcutaneous) from a pump, or a gel containing levodopa/carbidopa delivered by a pump inserted through the skin directly into the upper part of the small intestine (intestinal gel pump).
In June 2023, expert Parkinson’s clinicians and researchers led a course in Poland about current pump therapies and what may be coming in the future. In today’s episode, Professor Ray Chaudhuri, one of the course leaders and Director of the Parkinson’s Foundation Centre of Excellence at King’s College Hospital in London, discusses some of the topics in the course, including who would be a good candidate for pump therapy, the benefits and risks, and recent developments in pump treatment options.
Released: August 22, 2023
Want more?
Don't forget to subscribe! There are many ways to listen: Apple Podcasts, Google Play, TuneIn (Amazon Echo), Spotify or RSS Feed. (Need help subscribing? See our quick guide.)
For all of our Substantial Matters podcast episodes, visit Parkinson.org/Podcast.
Related Materials
Related Blog Posts
![Woman talking on the phone, holding a pill bottle](/sites/default/files/styles/500x360/public/images/Medications-whats-new-blog.jpg?h=ed9ce7df&itok=9-PCuBxk)
Parkinson’s & Medications: What's New?
![Father and son walking and hugging](/sites/default/files/styles/500x360/public/images/symptommanagement-pdmedicationaging-blog.jpg?h=b2774bcf&itok=QLN5hgg0)